Stocks and Investing
Stocks and Investing
Wed, January 5, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, January 4, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joshua Spector Maintained (CC) at Hold with Increased Target to $36 on, Jan 4th, 2022
Joshua Spector of UBS, Maintained "The Chemours Company" (CC) at Hold with Increased Target from $34 to $36 on, Jan 4th, 2022.
Joshua has made no other calls on CC in the last 4 months.
There is 1 other peer that has a rating on CC. Out of the 1 peers that are also analyzing CC, 0 agree with Joshua's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joshua
- Arun Viswanathan of "RBC Capital" Maintained at Buy with Increased Target to $45 on, Monday, November 8th, 2021
Contributing Sources